Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment
- 1 September 1995
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 23 (3), 268-277
- https://doi.org/10.1016/s0168-8278(95)80005-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Phenotyping of CYP2C19 with enantiospecific HPLCquantification of R- and S-mephenytoin and comparison with the intron4/exon5 G??? A-splice site mutationPharmacogenetics, 1995
- Specific and dose-dependent enzyme induction by omeprazole in human beingsHepatology, 1994
- Assessment of Liver Metabolic FunctionClinical Pharmacokinetics, 1994
- Variability in individual response to various doses of omeprazoleDigestive Diseases and Sciences, 1994
- Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolismBritish Journal of Clinical Pharmacology, 1993
- Pharmacokinetics of [14C]Omeprazole in Patients with Liver CirrhosisClinical Pharmacokinetics, 1993
- Pharmacokinetic Study of Omeprazole in Elderly Healthy VolunteersClinical Pharmacokinetics, 1992
- Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjectsPharmacogenetics, 1992
- Comparative tolerability profile of omeprazole in clinical trialsDigestive Diseases and Sciences, 1991
- OmeprazoleDrugs, 1991